We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Mavyret, a powerful treatment for Hepatitis C (HCV) in India. Understand how it works, its uses, dosage, potential side effects, and important precautions for patients.

Hepatitis C, a viral infection that primarily affects the liver, can be a serious long-term health concern if left untreated. Fortunately, advancements in medical science have provided effective treatment options. One such medication making a significant impact is Mavyret. This blog post aims to provide a comprehensive understanding of Mavyret, its uses, how it works, potential side effects, and important considerations for patients in India.
Mavyret is a brand-name prescription medication used to treat chronic (long-term) Hepatitis C Virus (HCV) infection in adults and children aged 3 years and older. It is a combination therapy, meaning it contains two active ingredients: glecaprevir and pibrentasvir. These are both direct-acting antiviral agents (DAAs) that work together to fight the HCV infection.
Mavyret is particularly useful because it can treat all major genotypes of HCV (genotypes 1 through 6) in certain individuals. This includes people who have previously been treated with other medications for genotype 1 HCV but did not achieve a cure. It is also prescribed for individuals who have compensated cirrhosis (mild liver scarring) or no cirrhosis at all.
Mavyret's mechanism of action is straightforward yet highly effective. The two active ingredients, glecaprevir and pibrentasvir, target different stages of the HCV lifecycle. They work by inhibiting key proteins that the virus needs to replicate and spread within the body. Essentially, Mavyret stops the virus from multiplying, allowing the body's immune system to clear the infection and leading to a cure.
Studies have shown that Mavyret is highly effective, with most people achieving a cure within the prescribed treatment duration, typically 8, 12, or 16 weeks. The duration of treatment depends on individual factors like your treatment history and the presence of liver cirrhosis.
Mavyret is prescribed for a wide range of individuals with chronic HCV infection. This includes:
Importantly, Mavyret is generally considered safe for individuals with kidney problems or those undergoing dialysis. However, it's crucial to discuss your complete medical history with your doctor before starting treatment.
The length of Mavyret treatment varies. It can typically range from 8, 12, or 16 weeks. Your doctor will determine the most appropriate duration for you based on several factors:
Regular blood tests will be conducted by your doctor to monitor your condition and the effectiveness of the treatment.
For adults and children aged 12 years and older, the standard dosage is three tablets taken once daily. For children between 3 and 12 years of age, the dosage is determined based on their body weight. Mavyret is available as oral tablets and pellets, both of which are swallowed.
Important Note: Always take Mavyret exactly as prescribed by your doctor. Do not stop taking the medication or alter the dosage without consulting your healthcare provider. If you miss a dose, take it as soon as you remember, but skip it if it's almost time for your next dose. Do not double up on doses.
A common scenario might be a patient who has tried older interferon-based therapies for Hepatitis C and found them difficult to tolerate or ineffective. They might be feeling discouraged but hopeful. Their doctor would then explain how Mavyret offers a newer, more effective, and generally better-tolerated option, often with a shorter treatment course.
Like all medications, Mavyret can cause side effects. Most side effects are mild and manageable. The most commonly reported side effects include:
Other possible side effects, though less common, can include:
Allergic Reactions: In rare cases, Mavyret can cause a severe allergic reaction. Symptoms may include swelling of the face, lips, tongue, or throat, difficulty breathing, hives, or severe dizziness. If you experience any signs of a severe allergic reaction, seek immediate medical attention by calling 108 (India's emergency number) or going to the nearest emergency room. For milder allergic reactions like a rash, contact your doctor promptly.
Mavyret carries a boxed warning regarding the risk of Hepatitis B virus (HBV) reactivation in individuals who have a history of HBV infection. This means that the dormant HBV in your body could become active again during or after Mavyret treatment. Your doctor will likely test you for HBV before starting Mavyret and may monitor you during and after treatment if you have a history of HBV.
Before starting Mavyret, inform your doctor about all your medical conditions, especially:
It is essential to tell your doctor about all the medications and supplements you are currently taking. Mavyret can interact with certain drugs, potentially affecting how well it works or increasing the risk of side effects. This includes certain antifungal medications, seizure medications, and St. John's Wort, an herbal supplement.
If you have Hepatitis C, it is strongly recommended to avoid alcohol consumption. Alcohol can further damage the liver and worsen the condition, potentially leading to severe cirrhosis. Discuss alcohol use with your doctor; they will likely advise complete abstinence during and after Mavyret treatment.
You should consult your doctor immediately if you:
The cost of Mavyret can vary significantly in India depending on the pharmacy, location, and insurance coverage (if applicable). As Mavyret is a prescription medication, it is generally available through licensed pharmacies. Patients are advised to consult their healthcare provider and local pharmacies for the most accurate pricing information and to explore any available patient assistance programs.
Yes, Mavyret is designed to cure chronic Hepatitis C in most people when taken as directed for the prescribed duration. A cure is typically confirmed when the virus is no longer detectable in blood tests after treatment is completed.
Currently, Mavyret is not available in a generic form. It is marketed under the brand name Mavyret, containing the active ingredients glecaprevir and pibrentasvir.
Mavyret has a boxed warning about the potential for Hepatitis B virus (HBV) reactivation in individuals with a history of HBV. This means that a dormant HBV infection could become active again. Your doctor will assess your risk and may perform tests and monitor you accordingly.
It is strongly recommended to avoid alcohol while being treated for Hepatitis C, including with Mavyret, as it can worsen liver damage. Your doctor will advise you on this.
Treatment duration typically ranges from 8 to 16 weeks, depending on factors such as your treatment history and the presence of liver cirrhosis.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026